No Data
Roth MKM Says Small-Cap Value Reaches Key Technical Support, Lists 14 "Bullish" Stocks
New Strong Buy Stocks for August 1st
Express News | Kiniksa Pharmaceuticals Ltd : JP Morgan Raises Target Price to $38 From $30
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $578,966, According to a Recent SEC Filing
Kiniksa Pharmaceuticals International(KNSA.US) Officer Sells US$3.49 Million in Common Stock
Kiniksa Pharmaceuticals International | 10-Q: Q2 2024 Earnings Report